CANY
CTIC

Caxton Associates (New York)’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Caxton Associates (New York)’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-55,530
Closed -$332K – 713
2022
Q2 		$332K Buy
55,530
+41,125
+285% +$246K 0.03% 339
2022
Q1 		$67K Buy
+14,405
New +$67K 0.01% 455